CD34+ progenitor cells in idiopathic (primary) myelofibrosis: A comparative quantification between spleen and bone marrow tissue

Annals of Hematology

Volumn 81, Issue 2, 2002, Pages 86-89

  Thiele, J ^a   Kvasnicka, H M ^a   Czieslick, C ^a  

^a UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Bone marrow; CD34+ progenitor cells; Idiopathic myelofibrosis; Morphometry; Spleen

Indexed keywords

CD34 ANTIGEN; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; BIOACCUMULATION; BONE MARROW; BONE MARROW BIOPSY; CELL COUNT; CELL POPULATION; CELL SEPARATION; CELL SIZE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; MYELOFIBROSIS; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SPLEEN; STEM CELL;

AGED; AGED, 80 AND OVER; ANTIGENS, CD34; BONE MARROW; CELL COUNT; FEMALE; HEMATOPOIETIC STEM CELLS; HUMANS; MALE; MIDDLE AGED; MYELOFIBROSIS; RETROSPECTIVE STUDIES; SPLEEN;

EID: 0036944424     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-001-0417-4     Document Type: Article

References (33)

1. Wolf BC, Neiman RS (1987) Hypothesis: splenic filtration and the pathogenesis of extramedullary hematopoiesis in agnogenic myeloid metaplasia. Hematol Pathol 1:77-80
2. Douay L, Laporte JP, Lefrancois G, Najman A, Dupuy-Montbrun MC, Lopez M, Giarratana MC, Gorin NC (1987) Blood and spleen haematopoiesis in patients with myelofibrosis. Leuk Res 11:725-730
3. Gilbert HS, Praloran V, Stanley ER (1989) Increased circulating CSF-1 (M-CSF) in myeloproliferative disease: association with myeloid metaplasia and peripheral bone marrow extension. Blood 74:1231-1234
4. Le Bousse-Kerdiles MC, Martyre MC (1999) Dual implication of fibrogenic cytokines in the pathogenesis of fibrosis and myeloproliferation in myeloid metaplasia with myelofibrosis. Ann Hematol 78:437-444
5. Hibbin JA, Njoku OS, Matutes E, Lewis SM, Goldman JM (1984) Myeloid progenitor cells in the circulation of patients with myelofibrosis and other myeloproliferative disorders. Br J Haematol 57:495-503
6. Partanen S, Ruutu T, Juvonen E, Pantzar P (1986) Effect of splenectomy on circulating haematopoietic progenitors in myelofibrosis. Scand J Haematol 37:87-90
7. Han ZC, Briere J, Nedellec G, Abgrall JF, Sensebe L, Parent D, Guern G (1988) Characteristics of circulating megakaryocyte progenitors (CFU-MK) in patients with primary myelofibrosis. Eur J Haematol 40:130-135
8. Koeffler HP, Cline MJ, Golde DW (1979) Splenic irradiation in myelofibrosis: effect on circulating myeloid progenitor cells. Br J Haematol 43:69-77
9. Kirshner JJ, Goldberg J, Landaw SA (1980) The spleen as a site of colony-forming cell production in myelofibrosis. Proc Soc Exp Biol Med 165:279-282
10. Partanen S, Ruutu T, Vuopio P (1982) Circulating haematopoietic progenitors in myelofibrosis. Scand J Haematol 29:325-330
11. Chervenick PA (1973) Increase in circulating stem cells in patients with myelofibrosis. Blood 41:67-71
12. Chikkappa G, Carsten AL, Chanana AD, Chandra P, Cronkite EP (1978) Increased granulocytic, erythrocytic, and megakaryocytic progenitors in myelofibrosis with myeloid metaplasia. Am J Hematol 4:121-131
13. Douer D, Fabian I, Cline MJ (1983) Circulating pluripotent haemopoietic cells in patients with myeloproliferative disorders. Br J Haematol 54:373-381
14. Grossi A, Vannucchi AM, Rafanelli D, Vannucchi L, Ferrini PR (1987) Megakaryocyte progenitors in the bone marrow and peripheral blood of patients with myeloproliferative diseases. Am J Hematol 25:371-376
15. Battegay EJ, Thomssen C, Nissen C, Gudat F, Speck B (1989) Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders. Eur J Haematol 42:321-326
16. Barosi G (1999) Myelofibrosis with myeloid metaplasia: diagnostic definition and prognostic classification for clinical studies and treatment guidelines. J Clin Oncol 17:2954-2970
17. Tefferi A (2000) Myelofibrosis with myeloid metaplasia. N Engl J Med 342:1255-1265
18. Orazi A, Neiman RS, Cualing H, Heerema NA, John K (1994) CD34 immunostaining of bone marrow biopsy specimens is a reliable way to classify the phases of chronic myeloid leukemia. Am J Clin Pathol 101:426-428
19. Thiele J, Klein H, Falk S, Bertsch HP, Fischer R, Stutte HJ (1992) Splenic megakaryocytopoiesis in primary (idiopathic) osteomyelofibrosis. An immunohistological and morphometric study with comparison of corresponding bone marrow features. Acta Haematol 87:176-180
20. Benbassat J, Gilon D, Penchas S (1990) The choice between splenectomy and medical treatment in patients with advanced agnogenic myeloid metaplasia. Am J Hematol 33:128-135
21. Barosi G, Ambrosetti A, Buratti A, Finelli C, Liberato NL, Quaglini S, Ricetti MM, Visani G, Tura S, Ascari E (1993) Splenectomy for patients with myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia 7:200-206
22. Lafaye F, Rain JD, Clot P, Najean Y (1994) Risks and benefits of splenectomy in myelofibrosis: an analysis of 39 cases. Nouv Rev Fr Hematol 36:359-362
23. Barosi G, Ambrosetti A, Centra A, Falcone A, Finelli C, Foa P, Grossi A, Guarnone R, Rupoli S, Luciano L, Petti MC, Pogliani E, Russo D, Ruggeri M, Quaglini S (1998) Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid Metaplasia. Blood 91: 3630-3636
24. Porcu P, Neiman RS, Orazi A (1999) Splenectomy in agnogenic myeloid metaplasia. Blood 93:2132-2134
25. Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN (2000) Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients. Blood 95:2226-2233
26. Mesa RA, Elliott MA, Tefferi A (2000) Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia. Blood Rev 14:121-129
27. Wolf BC, Luevano E, Neiman RS (1983) Evidence to suggest that the human fetal spleen is not a hematopoietic organ. Am J Clin Pathol 80:140-144
28. Wolf BC, Neiman RS (1985) Myelofibrosis with myeloid metaplasia: pathophysiologic implications of the correlation between bone marrow changes and progression of splenomegaly. Blood 65:803-809
29. Falk S, Mix D, Stutte HJ (1990) The spleen in osteomyelofibrosis. A morphological and immunohistochemical study of 30 cases. Virchows Arch A Pathol Anat Histopathol 416:437-442
30. Thiele J, Bennewitz FG, Bertsch HP, Falk S, Fischer R, Stutte HJ (1993) Splenic haematopoiesis in primary (idiopathic) osteomyelofibrosis: immunohistochemical and morphometric evaluation of proliferative activity of erytro- and endoreduplicative capacity of megakaryopoiesis (PCNA- and Ki-67 staining). Virchows Arch B Cell Pathol Incl Mol Pathol 64:281-286
31. Andreasson B, Swolin B, Kutti J (1997) Increase of CD34 positive cells in polycythaemia vera. Eur J Haematol 59:171-176
32. Liesveld JL, Winslow JM, Kempski MC, Ryan DH, Brennan JK, Abboud CN (1991) Adhesive interactions of normal and leukemic human CD34+ myeloid progenitors: role of marrow stromal, fibroblast, and cytomatrix components. Exp Hematol 19:63-70
33. Wang JC, Cheung CP, Ahmed F, Steier W, Tobin MS (1983) Circulating granulocyte and macrophage progenitor cells in primary and secondary myelofibrosis. Br J Haematol 54:301-307